France comprises Metropolitan France and several Overseas Departments and Regions, with healthcare administration coordinated nationally but delivered regionally through Regional Health Agencies (Agences Régionales de Santé). Funded primarily through social health insurance contributions and general taxation, the health system has established processes for medical evaluation, health technology assessment based on therapeutic value and improvement over existing treatments, with pricing negotiations based on comparative clinical benefit, and arrangements to ensure early patient access to innovative therapies.
If you would like to consult our Briefings please login at the top of the page or subscribe by clicking on the button below:
In this section subscribers can consult descriptions of the following stages of the national access process, with links to key sources of additional information:
- Healthcare system
- Access landscape
- Horizon scanning
- Scientific advice
- Regulatory approval
- Health technology assessment
- Price setting and rebate system
- Early access opportunities
- Additional funding opportunities
- Innovative medicines